For the readers interested in the stock health of Titan Pharmaceuticals Inc. (TTNP). It is currently valued at $0.14. When the transactions were called off in the previous session, Stock hit the highs of $0.16, after setting-off with the price of $0.1452. Company’s stock value dipped to $0.141 during the trading on the day. When the trading was stopped its value was $0.14.
Recently in News on October 28, 2020, Titan Pharmaceuticals Announces Pricing of $8.0 Million Underwritten Public Offering. Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) today announced the pricing of an underwritten public offering of 80,000,000 units at a price of $0.10 per unit. Each unit issued in the offering consists of one share of common stock and one warrant to purchase one share of common stock. Gross proceeds, before underwriting discounts and commissions and estimated offering expenses, are expected to be $8.0 million. You can read further details here
Get Ready for my next COVID-19 stock idea. I have been very fortunate in discovering biotech, therapeutic and diagnostic companies within the COVID-19 space, before wall street catches on. Our goal for our members is to get our Alert’s first before the crowd.
Titan Pharmaceuticals Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $0.5450 on 03/03/20, with the lowest value was $0.1128 for the same time period, recorded on 10/20/20.
Titan Pharmaceuticals Inc. (TTNP) full year performance was -22.04%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Titan Pharmaceuticals Inc. shares are logging -75.21% during the 52-week period from high price, and 19.77% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.11 and $0.55.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 9948304 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Titan Pharmaceuticals Inc. (TTNP) recorded performance in the market was -25.30%, having the revenues showcasing -50.17% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 16.19M, as it employees total of 21 workers.
Titan Pharmaceuticals Inc. (TTNP) in the eye of market guru’s
During the last month, 0 analysts gave the Titan Pharmaceuticals Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 0.2435, with a change in the price was noted -0.2449. In a similar fashion, Titan Pharmaceuticals Inc. posted a movement of -64.45% for the period of last 100 days, recording 9,809,515 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for TTNP is recording 3.06 at the time of this writing. In addition, long term Debt to Equity ratio is set at 2.06.
Titan Pharmaceuticals Inc. (TTNP): Stocks Technical analysis and Trends
Raw Stochastic average of Titan Pharmaceuticals Inc. in the period of last 50 days is set at 14.95%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 16.17%. In the last 20 days, the company’s Stochastic %K was 26.15% and its Stochastic %D was recorded 32.77%.
If we look into the earlier routines of Titan Pharmaceuticals Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -25.30%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -42.00%, alongside a downfall of -22.04% for the period of the last 12 months. The shares increased approximately by 10.52% in the 7-day charts and went up by -12.33% in the period of the last 30 days. Common stock shares were lifted by -50.17% during last recorded quarter.